NFKB1 and chronic obstructive pulmonary disease: Furthermore, the presence of hypercapnic and hypoxic environments, as is seen in COPD, hinders the expression of NF-κB, thereby disrupting the function of the innate immune system [31,32,44,45,46], which may potentially enable PDAC cells to evade the immune system.